Saya H, Ara S, Lee P S, Ro J, Hung M C
Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Mol Carcinog. 1990;3(4):198-201. doi: 10.1002/mc.2940030406.
The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu-encoded p185 protein. The human homologue of the rat neu gene, termed c-erbB-2 or HER-2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmembrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrane region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.
在大鼠神经/胶质母细胞瘤中发现neu基因是由编码neu基因所表达的p185蛋白跨膜区的DNA序列中的单点突变激活的。大鼠neu基因的人类同源基因,称为c-erbB-2或HER-2,在体外也可被相应区域的类似突变激活。尽管已证明人类neu基因在大部分人类乳腺癌和卵巢癌中扩增/过表达,但尚无报告表明人类neu基因在人类肿瘤中是由点突变激活的。为了研究人类肿瘤中neu基因可能存在的点突变,我们对人类neu基因跨膜区的基因组结构进行了表征,这反过来又使我们能够在通过聚合酶链反应进行DNA扩增后直接确定该区域的DNA序列。我们分析了7种肿瘤细胞系(2种乳腺癌、1种神经母细胞瘤、1种横纹肌肉瘤和3种神经胶质瘤)和11个肿瘤组织样本(8种乳腺癌和3种卵巢癌)。在人类neu基因的跨膜区未发现突变。我们的结果表明,与大鼠神经/胶质母细胞瘤不同,人类neu基因跨膜区的单点突变在人类肿瘤中是罕见事件。在本研究中,我们开发了一种对人类neu基因跨膜区进行直接DNA测序的技术。该技术使得筛查大量肿瘤样本成为可能。